Alprostadil liposome(Shanghai Shyndec Pharmaceutical)

1) To preliminarily investigate the safety and efficacy of different doses of alprostadil liposomes in the treatment of lower extremity arteriosclerosis obliterans; 2) To provide a basis for subsequent clinical research by comparing different doses of alprostadil liposomes in the treatment of lower extremity arteriosclerosis obliterans.